CIK 0001100682
- Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- Operating
- EIN
- 061397316
- Phone
- +1 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- Open-market buys, last 90 days
- $2,974
- in 1 filing
- Open-market sales, last 90 days
- $19,528,128
- in 4 filings, $19.5M under 10b5-1 plans
Net −$19,525,153. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-04 | BERTOLINI ROBERT J Director | Sale | −100 | $134.04 | $13K | 27,036 |
| 2018-12-04 | BERTOLINI ROBERT J Director | Sale | −200 | $134.05 | $27K | 26,836 |
| 2018-12-04 | BERTOLINI ROBERT J Director | Sale | −100 | $134.06 | $13K | 26,736 |
| 2018-12-04 | BERTOLINI ROBERT J Director | Sale | −100 | $134.10 | $13K | 26,636 |
| 2018-12-04 | BERTOLINI ROBERT J Director | Sale | −100 | $134.11 | $13K | 26,536 |
| 2018-12-04 | BERTOLINI ROBERT J Director | Sale | −100 | $134.16 | $13K | 26,436 |
| 2018-12-04 | BERTOLINI ROBERT J Director | Exercise or conversion · Stock Options (Right to Buy) | −4,540 | 0 | ||
| 2018-11-12 | Smith David Ross Corporate Executive VP & CFO | Sale | −100 | $134.47 | $13K | 12,341 |
| 2018-11-12 | Smith David Ross Corporate Executive VP & CFO | Sale | −1,466 | $134.50 | $197K | 10,875 |
| 2018-11-12 | Smith David Ross Corporate Executive VP & CFO | Sale | −100 | $134.40 | $13K | 10,775 |
| 2018-11-12 | Smith David Ross Corporate Executive VP & CFO | Sale | −200 | $134.47 | $27K | 10,575 |
| 2018-11-07 | JOHST DAVID P Corporate Executive VP | Exercise or conversion | +23,356 | $59.41 | $1.4M | 219,849 |
| 2018-11-07 | JOHST DAVID P Corporate Executive VP | Sale | −23,356 | $136.00 | $3.2M | 196,493 |
| 2018-11-07 | JOHST DAVID P Corporate Executive VP | Exercise or conversion · Stock Options (Right to Buy) | −23,356 | 0 | ||
| 2018-09-04 | Kochevar Deborah Turner Director | Sale | −300 | $123.23 | $37K | 10,190 |
| 2018-09-04 | Kochevar Deborah Turner Director | Sale | −200 | $123.39 | $25K | 9,990 |
| 2018-09-04 | Kochevar Deborah Turner Director | Sale | −100 | $123.46 | $12K | 9,890 |
| 2018-09-04 | Kochevar Deborah Turner Director | Sale | −100 | $123.47 | $12K | 9,790 |
| 2018-09-04 | Kochevar Deborah Turner Director | Sale | −100 | $123.49 | $12K | 9,690 |
| 2018-09-04 | Kochevar Deborah Turner Director | Sale | −200 | $123.50 | $25K | 9,490 |
Page 127 of 129 · 2,576 trades